Evidence map›Paper›PMID 40387391›Full record

ArticleMicrobiology spectrum2025

A clinical and molecular analysis of

Marius Surleac, Adriana Mihaela Stanciu, Dragoș Florea, Simona Paraschiv, Daniela Tălăpan, Mirela Flonta, Carmen Cristina Vasile, Gabriel Adrian Popescu, Dan Oțelea

Abstract read
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Emergence and Comparative Analysis ofJournal of fungi (Basel, Switzerland) · 2026
    Article
  2. Genomic landscape ofEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marius SurleacResearch Institute of the University of Bucharest, University of Bucharest, Bucharest, Romania.
Adriana Mihaela Stanciu"Prof. Dr. Matei Bals" National Institute of Infectious Diseases, Bucharest, Romania.ORCID 0009-0004-9060-6766
Dragoș Florea"Prof. Dr. Matei Bals" National Institute of Infectious Diseases, Bucharest, Romania.
Simona Paraschiv"Prof. Dr. Matei Bals" National Institute of Infectious Diseases, Bucharest, Romania.
Daniela Tălăpan"Prof. Dr. Matei Bals" National Institute of Infectious Diseases, Bucharest, Romania.
Mirela FlontaInfectious Diseases Clinical Hospital, Cluj Napoca, Romania.
Carmen Cristina Vasile"Prof. Dr. Matei Bals" National Institute of Infectious Diseases, Bucharest, Romania.
Gabriel Adrian Popescu"Prof. Dr. Matei Bals" National Institute of Infectious Diseases, Bucharest, Romania.
Dan Oțelea"Prof. Dr. Matei Bals" National Institute of Infectious Diseases, Bucharest, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Candida aurisCandidiasisSaccharomycetalesAdultAgedAged, 80 and overAntifungal AgentsDrug Resistance, FungalFemaleHigh-Throughput Nucleotide SequencingHumansMaleMicrobial Sensitivity TestsMiddle AgedMolecular EpidemiologyPhylogenyAntifungal AgentsCandida aurisemergent fungushealthcare-associated infections

Identifiers

PMID40387391
PMCPMC12210910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.